Hospital
ST. Vincent Hospital & Health Care Center, INC.
ST. Vincent Hospital & Health Care Center, INC. was paid $58.89M by Medicaid between Jan 2018 and Dec 2024, across 218 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoST. VINCENT HOSPITAL & HEALTH CARE CENTER, INC.
INDIANAPOLIS, IN 46260
INDIANAPOLIS, IN 46260
33aNPI1306898960assigned 05/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$58.89M
24GClaims889,862
24DCodes billed218
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#5 of 69
Median peer was paid$9.76M
This provider vs. median6.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,930 | $2.83M | |
| 2019 | 77,751 | $3.25M | |
| 2020 | 92,909 | $5.44M | |
| 2021 | 151,691 | $10.59M | |
| 2022 | 217,289 | $16.26M | |
| 2023 | 168,080 | $13.43M | |
| 2024incomplete | 100,212 | $7.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 76,106 | 67,364 | $13.32M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19% | 128,298 | 105,415 | $11.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.7% | 43,262 | 35,611 | $5.71M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 12,892 | 11,742 | $2.59M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 3.9% | 1,553 | 1,290 | $2.31M |
| 59425 | 3.4% | 15,536 | 12,689 | $1.99M | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.7% | 14,966 | 12,115 | $1.59M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.6% | 15,373 | 12,040 | $1.56M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 12,559 | 10,902 | $1.54M |
| 59426 | 2.4% | 11,896 | 8,690 | $1.41M | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.4% | 614 | 488 | $1.41M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.8% | 2,754 | 2,243 | $1.05M |
206 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 22,563 | $1.02M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 12,811 | $963K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 8,331 | $831K |
| 92558 | 1.3% | 7,309 | $792K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 9,971 | $715K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,247 | $555K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,336 | $524K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,877 | $465K |
| 92551 | <1% | 3,934 | $429K | |
| A0425 | Ground mileage, per statute mile | <1% | 6,011 | $428K |
| 59025 | Fetal non-stress test | <1% | 2,635 | $414K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,293 | $398K |
| 99173 | <1% | 13,631 | $359K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,320 | $354K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,361 | $292K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 1,916 | $277K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 62,120 | $271K |
| 59430 | <1% | 1,661 | $250K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,495 | $219K |
| 80053 | Comprehensive metabolic panel | <1% | 36,789 | $216K |
| 87634 | <1% | 3,098 | $194K | |
| 74018 | <1% | 1,265 | $191K | |
| 90670 | <1% | 10,065 | $165K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 1,131 | $147K |
| 99218 | <1% | 248 | $130K | |
| 99217 | <1% | 258 | $123K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,232 | $120K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,484 | $118K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,643 | $100K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,431 | $86K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 594 | $76K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 748 | $75K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 891 | $74K |
| 36416 | <1% | 9,465 | $69K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 584 | $69K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 180 | $69K |
| 90680 | <1% | 6,914 | $67K | |
| 81025 | <1% | 12,599 | $67K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,575 | $61K |
| 88342 | <1% | 580 | $60K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 349 | $59K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 161 | $51K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 533 | $50K |
| A0225 | Ambulance service, neonatal transport, base rate, emergency transport, one way | <1% | 645 | $49K |
| 90723 | <1% | 7,107 | $49K | |
| 99221 | <1% | 186 | $46K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 423 | $45K |
| 86832 | <1% | 760 | $45K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 403 | $43K |
| 86833 | <1% | 759 | $39K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 14,122 | $38K |
| 83655 | <1% | 2,922 | $36K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 60 | $36K |
| 94664 | <1% | 404 | $35K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 422 | $35K |
| 90651 | <1% | 1,039 | $34K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 370 | $32K |
| 84484 | <1% | 3,498 | $30K | |
| 99381 | <1% | 272 | $29K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 589 | $28K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 147 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 965 | $27K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 963 | $27K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,725 | $26K |
| 87799 | <1% | 927 | $22K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $21K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 145 | $21K |
| A0433 | Advanced life support, level 2 (als 2) | <1% | 118 | $21K |
| 81003 | <1% | 12,896 | $20K | |
| 81001 | <1% | 13,237 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,472 | $19K |
| G0378 | Hospital observation service, per hour | <1% | 132 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,073 | $18K |
| 87481 | <1% | 160 | $17K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 15 | $15K |
| 94010 | <1% | 163 | $14K | |
| 85018 | <1% | 5,445 | $13K | |
| 94760 | <1% | 115 | $12K | |
| 90734 | <1% | 1,175 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 51 | $10K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 169 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,401 | $8K |
| 83690 | <1% | 2,415 | $8K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 103 | $8K |
| 90677 | <1% | 1,548 | $8K | |
| 80305 | <1% | 1,029 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,248 | $7K |
| 73630 | <1% | 202 | $7K | |
| 85027 | <1% | 1,503 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 343 | $6K |
| 81002 | <1% | 18,802 | $6K | |
| 87512 | <1% | 179 | $6K | |
| 80197 | <1% | 3,471 | $6K | |
| 84702 | <1% | 696 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $6K |
| 95700 | <1% | 16 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 87 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 40 | $5K |
| A0422 | Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation | <1% | 1,052 | $5K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 160 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 81 | $5K |
| 83735 | <1% | 4,343 | $4K | |
| 92587 | <1% | 50 | $4K | |
| 83874 | <1% | 475 | $4K | |
| 95715 | <1% | 17 | $4K | |
| 90716 | <1% | 612 | $4K | |
| 97165 | <1% | 26 | $4K | |
| 86850 | <1% | 1,089 | $4K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 44 | $4K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 42 | $4K |
| 90837 | Psychotherapy session, about an hour | <1% | 48 | $4K |
| 87088 | <1% | 609 | $3K | |
| 61885 | <1% | 16 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 52,973 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 19 | $3K |
| 90620 | <1% | 107 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 83 | $3K |
| 82570 | <1% | 3,815 | $3K | |
| 82553 | <1% | 475 | $3K | |
| 87430 | <1% | 178 | $3K | |
| 82550 | <1% | 3,674 | $3K | |
| 76770 | <1% | 12 | $3K | |
| 97161 | <1% | 37 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 25 | $2K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 37 | $2K |
| 96127 | <1% | 35 | $2K | |
| 86900 | <1% | 1,151 | $2K | |
| 86901 | <1% | 1,171 | $2K | |
| 84100 | <1% | 3,937 | $2K | |
| 84550 | <1% | 3,789 | $2K | |
| 97162 | <1% | 12 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 43 | $2K |
| 88313 | <1% | 75 | $2K | |
| 84156 | <1% | 2,956 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $2K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 48 | $1K |
| 88720 | <1% | 384 | $1K | |
| 90461 | <1% | 7,107 | $1K | |
| 87081 | <1% | 160 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 19 | $981.80 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 57 | $902.31 |
| 87210 | <1% | 377 | $870.99 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 292 | $683.46 |
| 0001A | <1% | 280 | $669.78 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 407 | $651.04 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $612.36 |
| 88173 | <1% | 26 | $584.06 | |
| 83605 | <1% | 93 | $529.54 | |
| 92567 | <1% | 23 | $516.36 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 35 | $481.81 |
| 90686 | <1% | 22,301 | $444.60 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21,305 | $408.01 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $387.50 |
| 82977 | <1% | 74 | $384.46 | |
| 88304 | <1% | 697 | $372.96 | |
| 83880 | <1% | 16 | $365.12 | |
| 82150 | <1% | 74 | $346.17 | |
| 83615 | <1% | 73 | $333.51 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 22 | $318.06 |
| 88312 | <1% | 13 | $308.01 | |
| 0003A | <1% | 227 | $303.96 | |
| 80306 | <1% | 31 | $283.73 | |
| 82803 | <1% | 13 | $251.25 | |
| 86140 | <1% | 50 | $138.10 | |
| 85610 | <1% | 48 | $130.86 | |
| 82800 | <1% | 13 | $117.37 | |
| 80076 | <1% | 31 | $114.40 | |
| 85379 | <1% | 15 | $114.00 | |
| 0002A | <1% | 216 | $111.63 | |
| 90633 | <1% | 2,616 | $96.30 | |
| 80069 | <1% | 12 | $76.30 | |
| 84460 | <1% | 13 | $51.72 | |
| 84450 | <1% | 13 | $50.52 | |
| 84075 | <1% | 13 | $50.52 | |
| 82247 | <1% | 13 | $49.00 | |
| 84520 | <1% | 13 | $46.86 | |
| 82040 | <1% | 13 | $43.50 | |
| 0124A | <1% | 177 | $39.74 | |
| 84155 | <1% | 13 | $35.82 | |
| 90715 | <1% | 348 | $33.46 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 648 | $22.24 |
| 90674 | <1% | 468 | $21.73 | |
| 90480 | <1% | 14 | $7.92 | |
| 90661 | <1% | 85 | $4.81 | |
| 90700 | 0% | 394 | $0.00 | |
| 91312 | 0% | 163 | $0.00 | |
| 90685 | 0% | 434 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 42 | $0.00 |
| 90707 | 0% | 531 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 20 | $0.00 |
| 85014 | 0% | 99 | $0.00 | |
| 90710 | 0% | 437 | $0.00 | |
| 91300 | 0% | 870 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 38 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 57 | $0.00 |
| 90647 | 0% | 7,919 | $0.00 | |
| 90656 | 0% | 1,639 | $0.00 | |
| 90696 | 0% | 430 | $0.00 | |
| 80047 | 0% | 81 | $0.00 | |
| 99292 | 0% | 20 | $0.00 | |
| 90688 | 0% | 571 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 63 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 20 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 39 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 30 | $0.00 |
| 86352 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEHRMEISTER, ERICA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Memorial Surgery Center, LLC | Tulsa, OK | $3.19M |
| Bowden Gastro Associates LLC | Memphis, TN | $2.14M |
| Endoscopy Center of Lake County, LLC | Mentor, OH | $916K |
| East Columbus Surgery Center LLC | Columbus, OH | $740K |
| Pankratz Eye Institute, LLC | Columbus, IN | $30K |
| East Columbus Surgery Center LLC | Columbus, OH | $16K |
| Mayfield Spine Surgery Center LLC | Cincinnati, OH | $14K |
| G I Diagnostic and Therapeutic Center LLC | Germantown, TN | $9K |
| Lancaster Specialty Surgery Center LLC | Lancaster, OH | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.